Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin. According to our (Global Info Research) latest study, the global Somatostatin market size was valued at USD 346.3 million in 2022 and is forecast to a readjusted size of USD 715 million by 2029 with a CAGR of 10.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share over 65%. China is the largest market, followed by Europe and India. This report is a detailed and comprehensive analysis for global Somatostatin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Somatostatin market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029 Global Somatostatin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029 Global Somatostatin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2018-2029 Global Somatostatin market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Somatostatin To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Somatostatin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A. and Polypeptide Laboratories, Inc, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Somatostatin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type 0.25mg/pcs 0.75mg/pcs 3mg/pcs Market segment by Application Hormonal Disorder Oncology Metabolic Disorder Others Major players covered Merck (Schweiz) AG SANOFI-AVENTIS FRANCE Lyomark Pharma GmbH ALFA WASSERMANN S.p.A. Polypeptide Laboratories, Inc SAMARTH UBPL HYBIO TianTaiShan Yangtze River Siyao Shuangcheng Hainan Zhonghe SL PHARM Wuhan Hualong Qingdao Guoda Chengdu Shengnuo Longjin Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Somatostatin product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Somatostatin, with price, sales, revenue and global market share of Somatostatin from 2018 to 2023. Chapter 3, the Somatostatin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Somatostatin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Somatostatin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Somatostatin. Chapter 14 and 15, to describe Somatostatin sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Somatostatin 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Somatostatin Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 0.25mg/pcs 1.3.3 0.75mg/pcs 1.3.4 3mg/pcs 1.4 Market Analysis by Application 1.4.1 Overview: Global Somatosta
